key: cord-0910401-y8m3srso authors: Chen, Zhanghan; Qi, Zhipeng; He, Dongli; Liu, Jingyi; Xu, Enpan; Li, Bing; Cai, Shilun; Sun, Di; Cheng, Yirong; Shi, Qiang; Zhong, Yunshi title: Strategy for Scanning Peptide-Coding Circular RNAs in Colorectal Cancer Based on Bioinformatics Analysis and Experimental Assays date: 2022-02-25 journal: Front Cell Dev Biol DOI: 10.3389/fcell.2021.815895 sha: fa7e4e2c755073977f50f9013e5677c59017b77a doc_id: 910401 cord_uid: y8m3srso Background: Colorectal cancer (CRC) is the third most common cause of cancer deaths worldwide. Numerous studies have reported that circular RNAs (circRNAs) have important functions in CRC. It was first thought that circRNAs were non-coding RNA; however, more recently they were discovered to encode peptides and play a pivotal role in cancer development and progression. It was shown that most circRNAs possess coding potential; however, not all of them can truly encode peptides. Therefore, a practical strategy to scan for coding circRNAs is needed. Method: Sequence analyses included open reading frame (ORF) prediction, coding peptide prediction, and the identification of unique sequences. Then, experimental assays were used to verify the coded peptides, liquid chromatography-tandem mass spectrometry (LC-MS/MS) was introduced to detect sequences of circRNAs with coding potential, and Western blot was used to identify the encoded peptides. Finally, the functions of the circRNAs were primarily explored. Result: An efficient strategy for searching circRNAs with coding potential was created. We verified this schedule using public databases and LC-MS/MS, then two of these circRNAs were selected for further verification. We used commercial antibodies that can also identify the predicted peptides to test the coded peptides. The functions of the circRNAs were explored primarily, and the results showed that they were mainly involved in the promotion of proliferation and invasion ability. Discussion: We have constructed an efficient strategy of scanning circRNAs with coding potential. Our strategy helped to provide a more convenient pathway for identifying circRNA-derived peptides, which can be a potential therapeutic target or a diagnostic biomarker. Colorectal cancer (CRC) is now ranked third in terms of incidence and second in terms of mortality of all cancers worldwide (Sung et al., 2021) . Even with the popularization of endoscopic surgery and the improvement of CRC treatment, efficient and potent biomarkers for early diagnosis and therapeutic targets are still needed (Siegel et al., 2020; Sung et al., 2021) . Circular RNAs (circRNAs), a group of RNAs that possess a cyclic structure, were once believed to be non-coding and were reported to play a pivotal role in tumorigenesis and tumor development (Artemaki et al., 2020) . Mechanistically, the circRNAs can act as miRNA sponges and regulate downstream targets. Previous research found that circCAMSAP1 regulated by ESRP1 could sponge miR-328-5p and then target E2F1 to mediate CRC progression , and circHIPK3 could promote CRC proliferation and metastasis through the c-Myb/ circHIPK3/miR-7 axis (Zeng et al., 2018) . Moreover, circRNA can also interact with proteins and function as a tumor suppressor or promoter (Long et al., 2021) . Researchers found that circPTK2 could promote the epithelial-mesenchymal transition (EMT) of CRC cells by interacting with the Ser38, Ser55, and Ser82 sites of the vimentin protein . Another circRNA, circ_cse1l, can downregulate the expression of PCNA and inhibit the proliferation of CRC cells by binding to eIF4A3 (Xu et al., 2020) . It was not until recent years that circRNAs were discovered to have coding potential. Legnini et al. have identified a protein encoded by circ-ZNF609 in myogenesis (Legnini et al., 2017; Pamudurti et al., 2017) . Moreover, researchers have determined the translatomes of 80 human hearts and identified undetected microproteins, which also included peptides encoded by circRNAs (van Heesch et al., 2019) . Moreover, Zhang and his colleagues found several circRNAs that could encode peptides that functioned significantly in glioma Zhang et al., 2018; Xia et al., 2019; Gao et al., 2021; Wu et al., 2021a) . Furthermore, the coding potential of circRNAs can also be observed in liver cancer (Liang et al., 2019; Li et al., 2021) , gastric cancer (Jiang et al., 2021) , and colon cancer (Zheng et al., 2019; Pan et al., 2020) . Therefore, exploring the coding potential and functions of circRNAs is important. In this study, we developed an effective schedule to scan circRNAs that possessed coding potential in CRC and found two circRNAs that were most likely to encode peptides. Preliminarily, we verified the existence of coded peptides and the functions of their derived circRNAs. All eligible microarray datasets available up to December 2020 were downloaded from GEO (http://www.ncbi.nlm.nih.gov/gds/). The following search words were used: (circular RNA or circRNA) and (CRC or colorectal cancer). The filters were as follows: 1) at least five pairs of normal and cancer tissues, 2) no metastasis, 3) human solid tissues, and 4) arrays should have differentially expressed circRNAs between normal and cancer tissue after differential analysis. Two datasets were finally included in this study: GSE126095 and GSE142837. The R software was used to calibrate, standardize, and log 2 transform the downloaded files. The original sequences of circRNAs were downloaded from the circBase (http://www.circbase.org/). Then the open reading frames (ORFs) were predicted by using the getorf database (http://emboss.bioinformatics.nl/cgi-bin/emboss/getorf) with the sequence set as "circular." After infinite ORFs were excluded (Abe et al., 2015; Mo et al., 2019) , the amino acid (a. a.) sequences that spanned the junction sites of the circRNAs were selected. The batch effects between the datasets GSE126095 and GSE142837 were normalized by the sva package. Differential analysis was performed using the Limma package. The differentially expressed circRNAs met the standards: |log 2 FC| > 1 and adjust p-value <0.05. The coding potential of differentially expressed circRNAs was predicted by the following rules: 1) predicted ORF regions spanned the junction sites of circRNAs, 2) the predicted coded peptides had more than 50 a.a., and 3)the bases overlay less than 50 bps, which could make the peptides easier to identify. The databases circRNADb and circbank were introduced to evaluate the overall coding potential of differentially expressed circRNAs. Finally, the circRNA-derived peptides should have a unique sequence with more than two a.a. The flowchart is shown in Figure 1 . gDNA Eraser (TaKaRa, Tokyo, Japan; RR047A) and then applied to the ProFlex ™ PCR system (ABI, United States) to obtain cDNAs. The cDNA samples were mixed with SYBR Premix Ex Taq II (TaKaRa, Tokyo, Japan; RR820A) and quantified by using ABI QuantStudio 5 (ABI, United States); the reaction was initiated at 95°C for 1 min, then at 95°C for 5 s, and 60°C 30 s for a total of 40 cycles. The primers are listed in Supplementary Table S1 . Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was set as the internal reference. The 2 −ΔΔCt method was used to process the data. Radioimmunoprecipitation assay (RIPA) lysis buffer (Beyotime, China; P0013B) and protease and phosphatase inhibitor cocktail for general use (Beyotime, China; P1045) were used to obtain protein samples. Protein samples were denatured at 100°C for 10 min. Electrophoresis was started at 80 V to concentrate the protein and 120 V to separate the protein, then the transfer was conducted for 1 h under 300 mA. After blocking for 1 h with 5% non-fat milk (BD Biosciences, United States; 232100), the membranes were incubated overnight with primary antibodies BANP (ABclonal, China; A7595) and DHTKD1 (Santa Cruz Biotechnology, Inc., United States; sc-398620) at 4°C. After washing away the primary antibody with Tris-buffered saline Tween-20 (TBST), the secondary antibody (Abmart, China; M21003) was incubated for 1 h at room temperature. The bands were detected in automatic chemiluminescence and fluorescence analysis system (Tanon, China) by adding enhanced chemiluminescent reagent (NCM Biotech, China; P2200). To identify the unique a.a. sequence of circRNAs encoded peptides, the total protein was subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) sequencing and data analysis by Oebiotech Co., Ltd. (Shanghai, China). In brief, enzymolysis was performed using 0.02 μg/μl trypsin, and then the peptides were desalinated. The sample was analyzed using a Nano-HPLC liquid phase system EASY-NLC1200 and a Q-Exactive mass spectrometer. The acquired data were analyzed using ProteomeDiscover (V2.4, Thermo, United States) software. The cDNA from DLD-1 were amplified by PCR using a primer specifically targeting hsa_circ_0000725 and hsa_circ_0008826 and 2×Hieff ® PCR Master Mix (with dye) (Yeasen, China; 10102ES03). To confirm the junction sites, Sanger sequencing was conducted by using the primers listed in Supplementary Table S1 . To silence the circRNAs, siRNAs were synthesized by RIBOBIO (Guangzhou, China). Lipofectamine ™ RNAiMAX Transfection Reagent (Invitrogen, United States; 13778150) was used to transfect the siRNAs, and the efficiency was evaluated by qPCR. Cells (2,000 per well) were seeded in 96-well plates. EdU (RIBOBIO, China; C10310-3) and CCK-8 (BBI, China; E606335) reagents were used to estimate cell proliferative ability following the manufacture instructions. The images of EdU were analyzed by ImageJ, and the GraphPad Prism 7.0 software (GraphPad Software Inc., La Jolla, CA, United States) was used to analyze CCK-8 results. Cells (2,000 per well) were seeded in each well of a six-well plate. After 14 days of culture, the cells were fixed by 4% paraformaldehyde and stained by crystal violet. The images were analyzed by ImageJ. To evaluate cell invasion ability, each upper chamber (Biofil, China; TCS003024) with a 1:7 concentration of Matrigel membrane (BD Biosciences, United States; 356234) was seeded with 50,000 cells with the serum-free culture medium. The lower chambers were put into complete culture medium. After 72 h, the cells in the chambers were fixed by 4% paraformaldehyde and stained by crystal violet. Then, the upper chamber cells were cleared. The images were analyzed by ImageJ. In the cell cycle test, the cells were collected with cold phosphatebuffered saline (PBS) and fixed in 70% cold ethanol at −20°C overnight. After staining with propidine iodide (BD Biosciences, United States) for 30 min, the cells were loaded into a flow cytometer (BD Biosciences, United States), then 20,000-30,000 cells per tube were collected, and the results were analyzed by FlowJo (Version 10, United States). In the apoptosis test, the cells were suspended in Annexin-V binding buffer and then dyed using Annexin V combined fluorescein isothiocyanate (BD Biosciences, United States) and propidine iodide (BD Biosciences, United States) simultaneously in the dark for 15 min. The cells were loaded into a flow cytometer (BD Biosciences, United States), then 20,000-30,000 cells per tube were collected, and the results were analyzed by FlowJo (Version 10, United States). Frontiers in Cell and Developmental Biology | www.frontiersin.org February 2022 | Volume 9 | Article 815895 The Student's t-test was used to evaluate the difference. A twosided p-value <0.05 was considered statistically significant. Statistical analysis and graphs were constructed using GraphPad Prism 7.0 software (GraphPad Software Inc., La Jolla, CA, United States). According to our strategy (Figure 1) , we scanned the circRNAs with coding potential in CRC. First, to extend the candidate list, we compared the normal and CRC samples in the microarray datasets both together and separately. After deduplicating, the differential analysis found 965 differentially expressed circRNAs, including 836 circRNAs from the merge of GSE126095 and GSE142837 microarray datasets, 307 circRNAs from the GSE126095, and 5 circRNAs from the GSE142837 (Figure 2A ). Then we analyzed the sequences of these circRNAs; the predicted ORF should span the junction site of their circRNAs, and the predicted peptides should be over 50 a.a. so that the peptides were not too small to be detected. The circular structure of the circRNAs enabled their bps to be used more than one time. However, this repeated use can make the analysis very difficult, so we mainly focused on circRNAs that were predicted to have less than 50 bps for repeated use. This resulted in the exclusion of 603 circRNAs and left 362 circRNAs. Next, the databases circRNADb and circbank were introduced to evaluate the potential coding function, and 225 circRNAs were selected. Special sequences in the coding peptides from circRNAs were the identification codes of circRNAs themselves; we selected circRNAs that had more than two unique a.a. to ensure the quality of the following LC-MS/MS assays because only one unique a.a. can have many deviations, and the more a.a. detected the more convincing the results will be. A total of 57 circRNAs were identified (Table 1) , containing 46 upregulated circRNAs and 11 downregulated circRNAs Figure 2B . Besides, most of these circRNAs were derived from chromosomes 2 and 9, which may indicate their functions ( Figure 2C ). Experimentally, we tested the basic expression levels of the 57 circRNAs in a panel of seven CRC cell lines and one normal colorectal cell line NCM460 (data available under request). From those circRNAs, hsa_circ_0000725, hsa_circ_0007429, Frontiers in Cell and Developmental Biology | www.frontiersin.org February 2022 | Volume 9 | Article 815895 hsa_circ_0008501, and hsa_circ_0067080 were expressed significantly higher in most CRC cells, whereas hsa_circ_0005654 was expressed significantly lower in most CRC cells, which is the same as the differential analysis. However, the expressions of hsa_circ_0006088, hsa_circ_0007364, hsa_circ_0008199, and hsa_circ_0008826 were slightly varied in different CRC cells ( Figure 3A and Supplementary Figure S1A) . Coding Potential Evaluation of Candidate circRNAs Sequencing analysis found the unique a.a. sequence coded by the candidate circRNAs (Supplementary Table S2) . We also performed LC-MS/MS analysis to identify the 57 circRNAs. Strikingly, the LC-MS/MS results found the special sequences of nine circRNAs, including hsa_circ_0000725, has_circ_0007429, hsa_circ_0008501, hsa_circ_0067080, hsa_circ_0005654, hsa_circ_0006088, hsa_circ_0007364, hsa_circ_0008199, and hsa_circ_0008826 ( Figure 3B and Supplementary Figure S1B) . Exploration of the circRNAs showed that the hsa_circ_0000725 contained a complete ORF with 963 nt and might encode a 306-a.a. peptide; hsa_circ_0008826 contained a 1,499 nt ORF with the potential of encoding a 475-a.a. length peptide (Figures 3C, F) . The ORF structures of hsa_circ_0007429, hsa_circ_0008501, hsa_circ_0067080, hsa_circ_0005654, hsa_circ_0006088, hsa_circ_0007364, and hsa_circ_0008199 are shown in Supplementary Figure S2 . The a.a. sequence encoded by hsa_circ_0000725 had a 299-a.a. area in common with its host gene BANP; therefore, a commercial BANP antibody that targeted this area ( Figure 3D ) was used to detect the circBANP-306aa, and the Western blot identified a band at about 33.52 kDa ( Figure 3E) . Also, the a.a. encoded by hsa_circ_0008826 had a 439-a.a. area in common with its host gene DHTKD1; a commercial DHTKD1 antibody that targets this area ( Figure 3G ) was used to detect circDHTKD1-475aa, and the Western blot identified a band at about 53.48 kDa area ( Figure 3H ). The function of circRNAs-derived coding peptides may significantly relate to their derived circRNA. Therefore, we preliminarily explored the function of hsa_circ_0000725 and hsa_circ_0008826; their siRNAs were constructed and transfected into DLD-1. The siRNAs could efficiently silence the hsa_circ_0000725 and hsa_circ_0008826 in DLD-1 ( Figures 4A, B) . The CCK8 proliferation assay showed that the silencing of hsa_circ_0000725 and hsa_circ_0008826 could significantly inhibit the proliferation ability of DLD-1( Figure 4C ). The colony formation assay indicated that the silencing of hsa_circ_0000725 and hsa_circ_0008826 could significantly decrease the colony-forming ability of the DLD-1 ( Figure 4D) . The EdU staining also apparently showed the number of cells in a proliferation state decreased significantly when the silenced hsa_circ_0000725 and hsa_circ_0008826 were compared to the normal control in DLD-1 ( Figure 4E ). Silencing of hsa_circ_0000725 and hsa_circ_0008826 Could Also Influence the Cell Cycle, Apoptosis, and Invasion Ability of CRC Cells Flow cytometry assays found that the silencing of hsa_circ_0000725 could significantly lead to the accumulation in the G0/G1 stage of CRC cell, while the silencing of hsa_circ_0008826 showed a subtle change of cell cycle stages ( Figures 5A, B) . Meanwhile, apoptosis assays found that the silencing of hsa_circ_0000725 could promote apoptosis; however, the silencing of hsa_circ_0008826 made no difference in apoptosis ( Figures 5C, D) . The invasion assay showed that both hsa_circ_0000725 and hsa_circ_0008826 promoted the invasion ability of DLD-1 (Figures 5E, F) . As CRC has a high incidence and high mortality, early diagnosis and intervention methods are essential in the successful management of the disease. Thus, seeking efficient biomarkers for diagnosis or specific targets for treatment is an urgent priority. Numerous studies have found novel biomarkers and potential therapeutic targets for CRC (Mai et al., 2020; Feng et al., 2021; Ning et al., 2021; Sun et al., 2021; Wu et al., 2021b) . However, few can be introduced truly in clinical use. Therefore, finding stable and detectable molecules that can be used in clinical applications is important. CircRNAs possess a unique circle structure that is stable and easily detected. In the past, they were not believed to have coding ability. However, in recent years, a gradual number of studies have discovered that circRNAs can be cap-independent in translation (Pamudurti et al., 2017) , and the translation process can be conducted through other approaches, for example, IRESmediated and m6A-mediated (Yang et al., 2017) . Before our study, emerging evidence had shown the importance of the coding function of circRNAs. In 2017, Legnini and his colleagues first identified that circ-ZNF609, which specifically controls myoblast proliferation, can be translated into a protein in myogenesis (Legnini et al., 2017) . Another study illustrated the translational landscape of the human heart by analyzing the translatomes of 80 human hearts and also discovered the coding potential of circRNAs (van Heesch et al., 2019) . Our study has constructed a strategy that can be used to identify circRNAs with coding potential. The coding potential of circRNAs has promising application prospects. Recently, a study used the coding potential of circRNA to produce a circRNA vaccine that encoded the trimeric RBD of the SARS-CoV-2 spike protein with great efficacy, high design flexibility, and fast manufacturing speed compared to the traditional methods of vaccine production (Qu et al., 2021) . Peptides encoded by circRNAs also have important functions in other cancers. In CRC, it was reported that peptide circPPP1R12A-73aa encoded by hsa_circ_0000423 can promote tumor pathogenesis and metastasis of CRC through the Hippo pathway (Zheng et al., 2019) , and circFNDC3B-218aa encoded by circFNDC3B can regulate Snail to inhibit tumor progression and EMT in CRC (Pan et al., 2020) . Zhang and his colleagues found several circRNAs that could encode peptides and function significantly in glioma Zhang et al., 2018; Xia et al., 2019; Gao et al., 2021; Wu et al., 2021b) . The FBXW7-185aa encoded by circ-FBXW7 can inhibit the proliferation and cell cycle acceleration of glioma , and the circular SHPRH as well as circular AKT3 could encode Frontiers in Cell and Developmental Biology | www.frontiersin.org February 2022 | Volume 9 | Article 815895 tumor-suppressed peptides in glioblastoma Xia et al., 2019) . Meanwhile, a unique 14-a.a. peptide encoded by circ-E-Cad can promote the tumorigenicity of glioblastoma by activating the EGFR-STAT3 signal (Gao et al., 2021) . Moreover, the phenomenon of coding circRNAs has also been observed in liver cancer (Liang et al., 2019; Zheng et al., 2019) . The Wnt pathway is a classical tumor suppressor pathway; studies have found that circβ-catenin could influence a wide variety of Wnt pathway-related genes and encode a novel 370-a.a. peptide. This peptide can help to stabilize full-length βcatenin by antagonizing GSK3β-induced β-catenin phosphorylation and degradation (Liang et al., 2019) . Furthermore, a novel protein, MAPK1-109aa, encoded by circMAPK1, can inhibit the progression of gastric cancer by suppressing the activation of the MAPK pathway (Jiang et al., 2021) . Growing evidence has demonstrated the importance of circRNA-derived peptides in tumorigenesis and tumor development, which may be a potential biomarker or therapeutic target for cancer treatment in the future. Our strategy may be a convenient approach for searching the coding potential of circRNAs not only in CRC but also in other cancers. In this study, we constructed a strategy to efficiently search the coding potential circRNAs in CRC. In total, the candidate list lasts nine circRNAs, including hsa_circ_0000725, has_circ_0007429, hsa_circ_0008501, hsa_circ_0067080, hsa_circ_0005654, hsa_circ_0006088, hsa_circ_0007364, hsa_circ_0008199, and hsa_circ_0008826 ( Figures 3A, B and Supplementary Figures S1 and S2 ). Owing to the unique sequence of the novel peptides, we focused on those that had sequences identifiable by antibodies in their linear mRNA; two circRNAs were selected. Hsa_circ_0000725 and hsa_circ_0008826 were predicted to encode a 306-a.a. peptide and 475-a.a. peptide, respectively. Western blot analysis showed that hsa_circ_0000725-and hsa_circ_0008826derived peptides were expressed in multiple CRC cells, which is almost in accordance with the qPCR results. Then we preliminarily explore the function of hsa_circ_0000725 and hsa_circ_0008826; both of them could significantly promote the proliferation and colony formation as well as invasion ability of CRC. Besides, the silencing of hsa_circ_0000725 could lead to the accumulation of cells in the G0/G1 stage as well as the increase of apoptosis rate. In a word, these peptidecoding hsa_circ_0000725 and hsa_circ_0008826 could promote the proliferation as well as invasion ability of DLD-1; however, whether their coded peptides make the most contribution to this phenomenon still needs further validation. Our findings helped to construct a new schedule to scan potential coding circRNAs, which may be very practical in functional studies on circRNAs. However, our study still had limitations and shortcomings. The function of the circRNA itself could not be excluded, including the competing endogenous RNA (ceRNA) mechanism or RNA-binding protein mechanism. Whether the circRNA-derived peptides functioned in a pivotal role still needs further validation; specific antibodies are needed to identify these peptides, and overexpression vectors are needed to clarify the findings. Therefore, with the limitations considered, our preliminary exploration indicated that hsa_circ_0000725 and hsa_circ_0008826 possessed the ability of coding peptides and could promote the proliferation and invasion of CRC cells, but only hsa_circ_0000725 could influence the cell cycle and apoptosis rate of colorectal cells. Our strategy for scanning potential coding circRNAs was found to be effective. And these potential coding circRNAs may be good choices when seeking CRC therapeutic targets or diagnosis biomarkers. Publicly available datasets were analyzed in this study. These data can be found here: The data that support the findings of this study are available from the corresponding author upon reasonable request. Rolling Circle Translation of Circular RNA in Living Human Cells Circular RNAs: A New Piece in the Colorectal Cancer Puzzle CXCL12-mediated HOXB5 Overexpression Facilitates Colorectal Cancer Metastasis through Transactivating CXCR4 and ITGB3 Circular RNA-Encoded Oncogenic E-Cadherin Variant Promotes Glioblastoma Tumorigenicity through Activation of EGFR-STAT3 Signalling A Novel Protein Encoded by circMAPK1 Inhibits Progression of Gastric Cancer by Suppressing Activation of MAPK Signaling Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein Translation of the Circular RNA Circβ-Catenin Promotes Liver Cancer Cell Growth through Activation of the Wnt Pathway Comprehensive Landscape and Future Perspectives of Circular RNAs in Colorectal Cancer Serum piRNA-54265 Is a New Biomarker for Early Detection and Clinical Surveillance of Human Colorectal Cancer A Universal Approach to Investigate circRNA Protein Coding Function Exosomal miR-208b Related with Oxaliplatin Resistance Promotes Tregs Expansion in Colorectal Cancer Translation of CircRNAs A Novel Protein Encoded by circFNDC3B Inhibits Tumor Progression and EMT through Regulating Snail in colon Cancer Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants Colorectal Cancer Statistics, 2020. CA A 2-Hydroxylation of Fatty Acids Represses Colorectal Tumorigenesis and Metastasis via the YAP Transcriptional Axis Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries The Translational Landscape of the Human Heart MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1 A Novel Protein Encoded by Circular SMO RNA Is Essential for Hedgehog Signaling Activation and Glioblastoma Tumorigenicity A Novel Tumor Suppressor Protein Encoded by Circular AKT3 RNA Inhibits Glioblastoma Tumorigenicity by Competing with Active Phosphoinositide-dependent Kinase-1 Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3 CircPTK2 (Hsa_circ_0005273) as a Novel Therapeutic Target for Metastatic Colorectal Cancer Extensive Translation of Circular RNAs Driven by N6-Methyladenosine Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis CircHIPK3 Promotes Colorectal Cancer Growth and Metastasis by Sponging miR-7 A Novel Protein Encoded by the Circular Form of the SHPRH Gene Suppresses Glioma Tumorigenesis A Novel Protein Encoded by a Circular RNA circPPP1R12A Promotes Tumor Pathogenesis and Metastasis of colon Cancer via Hippo-YAP Signaling circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis Conflicts of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest ZC, ZQ, and DH contributed equally to this work. ZC, ZQ, and DH performed the experiments and wrote the manuscript. JL, EX, BL, SC, DS, and YC contributed to experiments and data analysis. YZ and QS designed the study. All authors approved the final version of the manuscript. Science and Technology (No. 19140901902, 18DZ1930302, 19140901902). We sincerely appreciate the guidance of Jianmin Xu and the invaluable assistance of Dexiang Zhu, Meiling Ji and Qi Lin during the current study.